Endocrine Society Calls for Longer Studies on Testosterone Therapy

As FDA Declares It Will Study Testosterone Therapy, Endocrine Society Calls for Longer, More Thorough Studies of the Drug At the end of January of this year, the Food and Drug Administration (FDA) said that it would investigate claims that testosterone therapy approved by the agency could lead to serious heart conditions in users, including … [Read more...]

Testosterone Therapy Drugs Should Carry Warning

Consumer Group Advocates for Black Box Warning Label on Testosterone Therapy A consumer advocacy group is petitioning the FDA to put a black box warning, the strongest warning label possible, on testosterone therapy drugs due to the potential for heart problems or stroke. Public Citizen added that the FDA should also require testosterone therapy … [Read more...]

FDA Panel Does Not Recommend Removing Chantix Warnings

FDA Review Panel Recommends Leaving Black Box Warnings on Chantix The FDA is set to review evidence submitted by Pfizer in their request to remove serious warnings from their anti-smoking drug, Chantix, which suggest that the drug can trigger depression and suicidal thoughts, among other side effects. However, an FDA review panel has looked at the … [Read more...]

FDA Will Examine Heart Risks of AstraZeneca Diabetes Drugs

Reports of Heart Failure Lead to FDA Probe into AstraZeneca Diabetes Drugs On Tuesday, February 11th, the Food and Drug Administration (FDA) announced that they would review claims that AstraZeneca diabetes drug saxagliptin (Onglyza and Kombiglyze XR name brands) after reports that the drug can lead to heart disease or failure. The agency has … [Read more...]

Uncle Ben’s Rice in School Lunches Under Food Recall

Potential Vitamin Overdose from Uncle Ben’s Rice Prompts Food Recall for Schools A potential vitamin overdose in Uncle Ben’s flavored rice has prompted a food recall for institutional-sized bags served as part of school lunches. The Food and Drug Administration (FDA) has warned consumers not to eat the rice, although there have been no reports so … [Read more...]

FDA Chief to Visit India Amid Generic Drug Concerns

Head of FDA Plans Visit to India as Concerns Grow Regarding Generic Drugs Manufactured There Amid rising concerns about the quality of generic drugs manufactured in India, FDA head Margaret A. Hamburg announced that she would head to the country to investigate some troubled manufacturers. Several generic drug manufactures in India have come under … [Read more...]

FDA Rejects Actos-Based Drug for the 2nd Time

In April of this year, the FDA rejected Takeda Pharmaceuticals’ Actos style new drug, called alogliptin, citing a lack of data regarding the drug’s side effects. Takeda Pharmaceuticals has been under fire in the last two years from patients who claim their drugs, specifically Avandia and Actos, cause severe side effects, and that Takeda knew about … [Read more...]

Dangerous Drugs Show Up in Supplements

Dangerous Drugs Banned by the FDA Show Up in Dietary Supplements A study published on Tuesday, October 21st, traced FDA recalls of dangerous drugs, including recalls of supplements that feature those dangerous drugs after they have been removed from the pharmaceutical market, and showed that many of those supplements do not get removed from retail … [Read more...]

Generic Wellbutrin pulled from the shelves

FDA announced certain generic Wellbutrin to be pulled off of the shelves. The 300 mg generic version of Wellbutrin XL made by Impax Laboratories and marketed by Teva Pharmaceuticals is being recalled.  Unusually, the recall is not because the medication has side effects, but rather because the medication doesn't work at all. This problem was not … [Read more...]

FDA Enforces Warning Labels on Testosterone Therapy

FDA Requires Warnings on Testosterone Therapy About Blood Clots On Thursday, June 19th, the Food and Drug Administration (FDA) announced that it would require warning labels on testosterone therapy, including AndroGel, that would inform consumers about the risks of blood clots and strokes. Postmarket studies of blood clot and stroke risks related … [Read more...]

BestLawyers.comAVBetter Business Bureau